Some immunotherapies and small molecule kinase inhibitors have been shown to cause “major fungal infections,” according to a study led by a researcher from Nutley, N.J.-based Hackensack Meridian Center for Discovery and Innovation.
Some immunotherapies and small molecule kinase inhibitors have been shown to cause “major fungal infections,” according to a study led by a researcher from Nutley, N.J.-based Hackensack Meridian Center for Discovery and Innovation.
Some immunotherapies and small molecule kinase inhibitors have been shown to cause “major fungal infections,” according to a study led by a researcher from Nutley, N.J.-based Hackensack Meridian Center for Discovery and Innovation.
Mark Cuban’s Cost Plus Drug Co. announced that beginning in July it will sell a branded Humira biosimilar known as Yusimry. It is the first biologic product offered by the company.
Mark Cuban’s Cost Plus Drug Co. announced that beginning in July it will sell a branded Humira biosimilar known as Yusimry. It is the first biologic product offered by the company.
St. Louis-based BJC HealthCare and Kansas City, Mo.-based St. Luke’s Health System said they will keep their individual brands as they form an integrated academic health system.